abstract |
The present invention provides a pharmaceutical composition or a pharmaceutically acceptable intermediate comprising the tannic acid glutinin complex or the complex. The present invention also relates to methods of preparing tannic acid citiglitin complex, as well as methods of using tannic acid citiglitin complex to treat diabetes, obesity and hypertension. |